The Journal of Urology
Volume 172, Issue 4, Part 1 , Pages 1297-1301, October 2004

THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?

From the Department of Urology, School of Medicine, Stanford University, Stanford, California

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Accepted for publication April 8, 2004.

PII: S0022-5347(05)61155-X

doi:10.1097/01.ju.0000139993.51181.5d

Refers to erratum:

  • RE: THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?

    The Journal of Urology June 2005 (Vol. 173, Issue 6, Pages 2205-2206)

  • RE: THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?

    T.A. Stamey, M. Caldwell, J.E. McNeal, R. Nolley, M. Hemenez, J. Downs
    The Journal of Urology June 2005 (Vol. 173, Issue 6, Page 2205)

The Journal of Urology
Volume 172, Issue 4, Part 1 , Pages 1297-1301, October 2004

Article Tools

* Image Usage & Resolution